Suchergebnisse - "Van Driest, Sara L"

PubPharm (5)

1

A fresh look at proton pump inhibitor (PPI)-associated adverse events through a CYP2C19 pharmacogenetic lens

enthalten in: Expert opinion on drug metabolism & toxicology | 2023

von Chevalier, R. | Attard, T. | Van Driest, S. | +1

CommentOn: Biomed Pharmacother. 2021 Nov;143:112234. - PMID 34649359

2

Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy

enthalten in: Clinical and translational science | 2022

von Tuteja, S. | Salloum, R. | Elchynski, A. | +26

3

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing

enthalten in: Clinical pharmacology and therapeutics | 2021

von Lima, J. | Thomas, C. | Barbarino, J. | +17

4

Authors' Response

enthalten in: Pediatrics | 2020

von Van Driest, S. | Bernal, C.

CommentOn: Pediatrics. 2019 Dec;144(6):. - PMID 31699831

5

CYP2C19 Phenotype and Risk of Proton Pump Inhibitor-Associated Infections

enthalten in: Pediatrics | 2019

von Bernal, C. | Aka, I. | Carroll, R. | +5

CommentIn: Pediatrics. 2019 Dec;144(6):. - PMID 31699830

1
[1]